UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 7, 2007
PetMed Express, Inc.
---------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 000-28827 65-0680967
---------------------------------------------------------------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
1441 S.W. 29th Avenue, Pompano Beach, FL 33069
---------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(954) 979-5995
---------------------------------------------------------------------------
(Registrant's telephone number, including area code)
Not Applicable
---------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
___________________________________________________________________________
Item 8.01 Other Events.
On May 7, 2007, PetMed Express, Inc. issued a press release stating
that it will announce its March 31, 2007 year end financial results
and host a conference call to review the results on Monday, May 14,
2007. A copy of this press release is attached hereto as Exhibit 99.1
and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 - Press release dated May 7, 2007.
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press release dated May 7, 2007
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Dated: May 7, 2007
PETMED EXPRESS, INC.
By: /s/ Bruce S. Rosenbloom
-------------------------------
Name: Bruce S. Rosenbloom
Title: Chief Financial Officer
2
___________________________________________________________________________
Exhibit 99.1
PETMED EXPRESS D/B/A 1-800-PETMEDS TO ANNOUNCE ITS FISCAL YEAR END
FINANCIAL RESULTS ON MAY 14, 2007
Pompano Beach, Florida, May 7, 2007 - PetMed Express, Inc. (NASDAQ:
PETS) will announce its financial results for the year ended March 31,
2007 on Monday, May 14, 2007 at 8:00 A.M. Eastern Time, then at 8:30
A.M. Eastern Time, Menderes Akdag, the Company's Chief Executive
Officer and President, will host a conference call to review the
financial results.
To access the call, which is open to the public, dial (888) 455-1758
(toll free) or (312) 470-7365, ten minutes prior to the scheduled
start time. Callers will be required to supply PETMEDS as the
passcode, and will be placed on hold with music until the call begins.
For those unable to participate in the live event, the call will be
available for replay from 10:00 A.M. on May 14, 2007 until May 28,
2007 at 11:59 P.M. To access the replay, call (866) 507-3617 (toll
free) or (203) 369-1891, and enter passcode 5500.
Founded in 1996, PetMed Express is America's Largest Pet Pharmacy,
delivering prescription and non-prescription pet medications and other
health products for dogs, cats, and horses at competitive prices
direct to the consumer through its 1-800-PetMeds toll free number and
on the Internet through its website at www.1800petmeds.com.
-------------------
This press release may contain "forward-looking" statements, as
defined in the Private Securities Litigation Reform Act of 1995 or by
the Securities and Exchange Commission, that involve a number of risks
and uncertainties, including the Company's ability to meet the
objectives included in its business plan. Important factors that
could cause results to differ materially from those indicated by such
"forward-looking" statements are set forth in Management's Discussion
and Analysis of Financial Condition and Results of Operation in the
PetMed Express Annual Report on Form 10-K for the year ended March 31,
2006. The Company's future results may also be impacted by other risk
factors listed from time to time in its SEC filings, including, but
not limited to, the Company's Form 10-Q and its Annual Report on Form
10-K.
For investment relations contact PetMed Express, Inc., Bruce S.
Rosenbloom, CFO, 954-979-5995.
###
Exhibit 99.1 Page 1 of 1
___________________________________________________________________________